Literature DB >> 10582926

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

T Panagiotopoulos1, I Antoniadou, E Valassi-Adam.   

Abstract

OBJECTIVE: To describe the events leading to the epidemic of congenital rubella syndrome in Greece in 1993 after a major rubella epidemic.
DESIGN: Retrospective survey and systematic review.
SETTING: Greece (population 10 million), 1950-95.
SUBJECTS: Children, adolescents, and women of childbearing age.
RESULTS: Around 1975 in Greece the measles, mumps, and rubella vaccine started being given to boys and girls aged 1 year without policies to attain high vaccination coverage and to protect adolescents and young women. During the 1980s, vaccination coverage for rubella remained consistently below 50%, and the proportion of pregnant women susceptible to rubella gradually increased. In 1993 the incidence of rubella in young adults was higher than in any previous epidemic year. The epidemic of congenital rubella that followed, with 25 serologically confirmed cases (24.6 per 100 000 live births), was probably the largest such epidemic in Greece after 1950.
CONCLUSIONS: With low vaccination coverage, the immunisation of boys and girls aged 1 year against rubella carries the theoretical risk of increasing the occurrence of congenital rubella. This phenomenon, which has not been previously reported, occurred in Greece.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582926      PMCID: PMC28289          DOI: 10.1136/bmj.319.7223.1462

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

Review 1.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 2.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.

Authors:  F T Cutts; S E Robertson; J L Diaz-Ortega; R Samuel
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 3.  Measles and rubella in the United States.

Authors:  H W Hethcote
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

4.  Vaccination against rubella and measles: quantitative investigations of different policies.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1983-04

5.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

6.  Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination.

Authors:  M Böttiger; M Forsgren
Journal:  Vaccine       Date:  1997-10       Impact factor: 3.641

7.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

8.  Universal immunization to interrupt rubella.

Authors:  K J Bart; W A Orenstein; S R Preblud; A R Hinman
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

9.  Theoretical aspects of rubella vaccination strategies.

Authors:  E G Knox
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

10.  Strategy for rubella vaccination.

Authors:  E G Knox
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

View more
  50 in total

1.  Vaccination policies: individual rights v community health. We can't afford to be half hearted about vaccination programmes.

Authors:  S King
Journal:  BMJ       Date:  1999-12-04

2.  Incidence of congenital rubella in Greece has decreased.

Authors:  G Giannakos; M Pirounaki; C Hadjichristodoulou
Journal:  BMJ       Date:  2000-05-20

3.  Health professionals do not understand mathematical models.

Authors:  W J Edmunds; N J Gay
Journal:  BMJ       Date:  2000-02-26

4.  Incidence of congenital rubella in Greece.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  2000-11-18

5.  Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana.

Authors:  J E Lawn; S Reef; B Baffoe-Bonnie; S Adadevoh; E O Caul; G E Griffin
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

6.  Rubella seroprofile of the Italian population: an 8-year comparison.

Authors:  M C Rota; A Bella; G Gabutti; C Giambi; A Filia; M Guido; A De Donno; P Crovari; M L Ciofi Degli Atti
Journal:  Epidemiol Infect       Date:  2006-11-01       Impact factor: 2.451

7.  Seroepidemiology of rubella in northern Greece.

Authors:  G Gioula; E Diza-Mataftsi; S Alexiou-Daniel; V Kyriazopoulou-Dalaina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-08       Impact factor: 3.267

8.  Short-term Prediction of the Incidence of Congenital Rubella Syndrome.

Authors:  Yasushi Ohkusa; Tamie Sugawara; Satoru Arai; Hiroshi Satoh; Hideo Okuno; Keiko Tanaka-Taya; Kazunori Oishi
Journal:  PLoS Curr       Date:  2014-10-30

9.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

10.  Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Francesca Russo; Marta Cecilia Busana; Cinzia Piovesan; Greta Bordignon; Aurore Giliberti; Renzo Trivello
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.